nodes	percent_of_prediction	percent_of_DWPC	metapath
Ingenol Mebutate—PRKCA—Metabolism—GOT2—liver cancer	0.000131	0.000131	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—CDKN2A—liver cancer	0.000131	0.000131	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—PIK3CB—liver cancer	0.000131	0.000131	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—PIK3CB—liver cancer	0.000131	0.000131	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—CSF2—liver cancer	0.000131	0.000131	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—CDKN1B—liver cancer	0.00013	0.00013	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—HRAS—liver cancer	0.000129	0.000129	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—ABL1—liver cancer	0.000128	0.000128	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism of mRNA—AKT1—liver cancer	0.000127	0.000127	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—PIK3CD—liver cancer	0.000127	0.000127	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Platelet activation, signaling and aggregation—AKT1—liver cancer	0.000127	0.000127	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—PIK3CA—liver cancer	0.000126	0.000126	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—SERPINE1—liver cancer	0.000125	0.000125	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—PIK3CA—liver cancer	0.000125	0.000125	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—PRKCE—liver cancer	0.000125	0.000125	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—CCND1—liver cancer	0.000124	0.000124	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—CYP2E1—liver cancer	0.000123	0.000123	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—RAF1—liver cancer	0.000122	0.000122	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—RAF1—liver cancer	0.000121	0.000121	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—HGF—liver cancer	0.000121	0.000121	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—IL2—liver cancer	0.00012	0.00012	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—IL2—liver cancer	0.00012	0.00012	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—ADAM17—liver cancer	0.00012	0.00012	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—TERT—liver cancer	0.00012	0.00012	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—CDKN1A—liver cancer	0.00012	0.00012	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—PIK3CB—liver cancer	0.00012	0.00012	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—MTOR—liver cancer	0.00012	0.00012	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CD8A—liver cancer	0.000119	0.000119	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CSF2—liver cancer	0.000119	0.000119	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Neuronal System—HRAS—liver cancer	0.000119	0.000119	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—PIK3CB—liver cancer	0.000118	0.000118	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—MTOR—liver cancer	0.000118	0.000118	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—H2AFX—liver cancer	0.000117	0.000117	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—HRAS—liver cancer	0.000117	0.000117	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—CDKN1B—liver cancer	0.000116	0.000116	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—HRAS—liver cancer	0.000116	0.000116	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—CYCS—liver cancer	0.000115	0.000115	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—AKT1—liver cancer	0.000114	0.000114	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—RAF1—liver cancer	0.000113	0.000113	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—GGT1—liver cancer	0.000113	0.000113	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—GOT1—liver cancer	0.000113	0.000113	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—F2—liver cancer	0.000113	0.000113	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PSMD10—liver cancer	0.000113	0.000113	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PSMA4—liver cancer	0.000113	0.000113	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—CDKN1B—liver cancer	0.000112	0.000112	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—IL6—liver cancer	0.000112	0.000112	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—IL6—liver cancer	0.000111	0.000111	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—CCND1—liver cancer	0.000111	0.000111	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—CDKN1B—liver cancer	0.000111	0.000111	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—PIK3CB—liver cancer	0.00011	0.00011	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—MTOR—liver cancer	0.00011	0.00011	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—IL2—liver cancer	0.00011	0.00011	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—KDR—liver cancer	0.00011	0.00011	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism of RNA—AKT1—liver cancer	0.000109	0.000109	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—MAPK14—liver cancer	0.000109	0.000109	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—H2AFX—liver cancer	0.000109	0.000109	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—PIK3CG—liver cancer	0.000108	0.000108	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—CDKN1A—liver cancer	0.000107	0.000107	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—JUN—liver cancer	0.000107	0.000107	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—ESR1—liver cancer	0.000107	0.000107	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—CTNNB1—liver cancer	0.000106	0.000106	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—F2—liver cancer	0.000105	0.000105	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—JUN—liver cancer	0.000105	0.000105	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—CTNNB1—liver cancer	0.000105	0.000105	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—PPARA—liver cancer	0.000104	0.000104	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—CDKN1B—liver cancer	0.000104	0.000104	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—CDKN1A—liver cancer	0.000104	0.000104	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—AKT1—liver cancer	0.000103	0.000103	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—F2—liver cancer	0.000103	0.000103	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—AKT1—liver cancer	0.000102	0.000102	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—VEGFA—liver cancer	0.000102	0.000102	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—CDKN1A—liver cancer	0.000102	0.000102	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—BCL2L1—liver cancer	0.000102	0.000102	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—GSTP1—liver cancer	0.000102	0.000102	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—MAPK8—liver cancer	0.000101	0.000101	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—PIK3CG—liver cancer	0.000101	0.000101	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—APC—liver cancer	0.000101	0.000101	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—HMOX1—liver cancer	0.0001	0.0001	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—MAPK8—liver cancer	9.97e-05	9.97e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—MYC—liver cancer	9.93e-05	9.93e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—MTHFR—liver cancer	9.85e-05	9.85e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—TERT—liver cancer	9.82e-05	9.82e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—PIK3CG—liver cancer	9.81e-05	9.81e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—CTNNB1—liver cancer	9.79e-05	9.79e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—MAPK14—liver cancer	9.67e-05	9.67e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—MAPK14—liver cancer	9.61e-05	9.61e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—CDKN1A—liver cancer	9.56e-05	9.56e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—PIK3CD—liver cancer	9.5e-05	9.5e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—BRAF—liver cancer	9.48e-05	9.48e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by Wnt—AKT1—liver cancer	9.48e-05	9.48e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—ESR1—liver cancer	9.43e-05	9.43e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—TGFB1—liver cancer	9.38e-05	9.38e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—GSTM1—liver cancer	9.33e-05	9.33e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—STAT3—liver cancer	9.24e-05	9.24e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—MYC—liver cancer	8.88e-05	8.88e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—PIK3CD—liver cancer	8.87e-05	8.87e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—CYP1A1—liver cancer	8.85e-05	8.85e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—PIK3CA—liver cancer	8.79e-05	8.79e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—SERPINE1—liver cancer	8.77e-05	8.77e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PRKCE—liver cancer	8.72e-05	8.72e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—KRAS—liver cancer	8.69e-05	8.69e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—KRAS—liver cancer	8.68e-05	8.68e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—PIK3CD—liver cancer	8.62e-05	8.62e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—PPARG—liver cancer	8.6e-05	8.6e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—MYC—liver cancer	8.54e-05	8.54e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—STAT3—liver cancer	8.53e-05	8.53e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—PIK3CB—liver cancer	8.28e-05	8.28e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—APC—liver cancer	8.28e-05	8.28e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—IGF2—liver cancer	8.26e-05	8.26e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CDH1—liver cancer	8.25e-05	8.25e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—MTHFR—liver cancer	8.25e-05	8.25e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—PPARA—liver cancer	8.09e-05	8.09e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—PIK3CA—liver cancer	7.98e-05	7.98e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—PIK3CA—liver cancer	7.98e-05	7.98e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—KRAS—liver cancer	7.93e-05	7.93e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—MYC—liver cancer	7.93e-05	7.93e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—RAF1—liver cancer	7.92e-05	7.92e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—TGFB1—liver cancer	7.91e-05	7.91e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—PIK3CD—liver cancer	7.88e-05	7.88e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—KRAS—liver cancer	7.82e-05	7.82e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—BRAF—liver cancer	7.78e-05	7.78e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—SERPINE1—liver cancer	7.75e-05	7.75e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—PIK3CB—liver cancer	7.73e-05	7.73e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—MTOR—liver cancer	7.73e-05	7.73e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—TP53—liver cancer	7.72e-05	7.72e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CSF2—liver cancer	7.72e-05	7.72e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—RAF1—liver cancer	7.7e-05	7.7e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—H2AFX—liver cancer	7.61e-05	7.61e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—IL2—liver cancer	7.6e-05	7.6e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—PIK3CB—liver cancer	7.52e-05	7.52e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—HRAS—liver cancer	7.39e-05	7.39e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—HRAS—liver cancer	7.38e-05	7.38e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—KRAS—liver cancer	7.33e-05	7.33e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—PIK3CA—liver cancer	7.29e-05	7.29e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—TP53—liver cancer	7.29e-05	7.29e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—PIK3CD—liver cancer	7.27e-05	7.27e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CDKN1B—liver cancer	7.26e-05	7.26e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—SERPINE1—liver cancer	7.2e-05	7.2e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—PIK3CA—liver cancer	7.19e-05	7.19e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—AKT1—liver cancer	7.18e-05	7.18e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CASP3—liver cancer	7.11e-05	7.11e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—IL2—liver cancer	7.1e-05	7.1e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—IL6—liver cancer	7.06e-05	7.06e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—RAF1—liver cancer	7.03e-05	7.03e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—PIK3CG—liver cancer	6.93e-05	6.93e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CCND1—liver cancer	6.92e-05	6.92e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—JUN—liver cancer	6.91e-05	6.91e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—IL2—liver cancer	6.9e-05	6.9e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—TERT—liver cancer	6.88e-05	6.88e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—MTOR—liver cancer	6.87e-05	6.87e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—PIK3CB—liver cancer	6.87e-05	6.87e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CTNNB1—liver cancer	6.85e-05	6.85e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—HRAS—liver cancer	6.74e-05	6.74e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—PIK3CA—liver cancer	6.73e-05	6.73e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—MMP9—liver cancer	6.72e-05	6.72e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CDKN1A—liver cancer	6.7e-05	6.7e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—PPARG—liver cancer	6.69e-05	6.69e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—HRAS—liver cancer	6.65e-05	6.65e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—MAPK8—liver cancer	6.54e-05	6.54e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—AKT1—liver cancer	6.52e-05	6.52e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—AKT1—liver cancer	6.52e-05	6.52e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—RAF1—liver cancer	6.49e-05	6.49e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—IL6—liver cancer	6.45e-05	6.45e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CDKN1B—liver cancer	6.45e-05	6.45e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—IL6—liver cancer	6.37e-05	6.37e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—MTOR—liver cancer	6.34e-05	6.34e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—PIK3CB—liver cancer	6.34e-05	6.34e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—IL2—liver cancer	6.31e-05	6.31e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—KDR—liver cancer	6.29e-05	6.29e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—MAPK14—liver cancer	6.25e-05	6.25e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—HRAS—liver cancer	6.23e-05	6.23e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—JUN—liver cancer	6.14e-05	6.14e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—ESR1—liver cancer	6.13e-05	6.13e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—PIK3CD—liver cancer	6.09e-05	6.09e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CTNNB1—liver cancer	6.09e-05	6.09e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—F2—liver cancer	6.06e-05	6.06e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—VEGFA—liver cancer	6.03e-05	6.03e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—ALB—liver cancer	6.01e-05	6.01e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—STAT3—liver cancer	5.97e-05	5.97e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—IL6—liver cancer	5.96e-05	5.96e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—AKT1—liver cancer	5.95e-05	5.95e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—CDKN1B—liver cancer	5.95e-05	5.95e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CDKN1A—liver cancer	5.95e-05	5.95e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—AKT1—liver cancer	5.92e-05	5.92e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—AKT1—liver cancer	5.87e-05	5.87e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—MAPK8—liver cancer	5.81e-05	5.81e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—APC—liver cancer	5.8e-05	5.8e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PIK3CG—liver cancer	5.8e-05	5.8e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—CTNNB1—liver cancer	5.62e-05	5.62e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—MYC—liver cancer	5.55e-05	5.55e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—TGFB1—liver cancer	5.54e-05	5.54e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—AKT1—liver cancer	5.5e-05	5.5e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—CDKN1A—liver cancer	5.49e-05	5.49e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—BRAF—liver cancer	5.45e-05	5.45e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—PIK3CB—liver cancer	5.31e-05	5.31e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—STAT3—liver cancer	5.31e-05	5.31e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—KRAS—liver cancer	5.13e-05	5.13e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PIK3CD—liver cancer	5.09e-05	5.09e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—PIK3CA—liver cancer	5.05e-05	5.05e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—SERPINE1—liver cancer	5.04e-05	5.04e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—KRAS—liver cancer	4.99e-05	4.99e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—MYC—liver cancer	4.9e-05	4.9e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—STAT3—liver cancer	4.9e-05	4.9e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—PIK3CA—liver cancer	4.71e-05	4.71e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—PIK3CA—liver cancer	4.58e-05	4.58e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—TP53—liver cancer	4.56e-05	4.56e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—KRAS—liver cancer	4.56e-05	4.56e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—MYC—liver cancer	4.55e-05	4.55e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—RAF1—liver cancer	4.55e-05	4.55e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—TGFB1—liver cancer	4.54e-05	4.54e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PIK3CB—liver cancer	4.44e-05	4.44e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—MTOR—liver cancer	4.44e-05	4.44e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—HRAS—liver cancer	4.36e-05	4.36e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—HRAS—liver cancer	4.24e-05	4.24e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—KRAS—liver cancer	4.21e-05	4.21e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—PIK3CA—liver cancer	4.19e-05	4.19e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—IL6—liver cancer	4.17e-05	4.17e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CDKN1B—liver cancer	4.17e-05	4.17e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—AKT1—liver cancer	4.12e-05	4.12e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CASP3—liver cancer	4.08e-05	4.08e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—IL2—liver cancer	4.08e-05	4.08e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—IL6—liver cancer	4.06e-05	4.06e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CCND1—liver cancer	3.98e-05	3.98e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—JUN—liver cancer	3.97e-05	3.97e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CTNNB1—liver cancer	3.94e-05	3.94e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—HRAS—liver cancer	3.87e-05	3.87e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—PIK3CA—liver cancer	3.87e-05	3.87e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—MMP9—liver cancer	3.86e-05	3.86e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—AKT1—liver cancer	3.85e-05	3.85e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CDKN1A—liver cancer	3.85e-05	3.85e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—MAPK8—liver cancer	3.75e-05	3.75e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—AKT1—liver cancer	3.74e-05	3.74e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—IL6—liver cancer	3.71e-05	3.71e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—HRAS—liver cancer	3.58e-05	3.58e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—VEGFA—liver cancer	3.47e-05	3.47e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—STAT3—liver cancer	3.43e-05	3.43e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—IL6—liver cancer	3.42e-05	3.42e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—AKT1—liver cancer	3.42e-05	3.42e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—AKT1—liver cancer	3.4e-05	3.4e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—PIK3CA—liver cancer	3.24e-05	3.24e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—MYC—liver cancer	3.19e-05	3.19e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—TGFB1—liver cancer	3.18e-05	3.18e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—AKT1—liver cancer	3.16e-05	3.16e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—KRAS—liver cancer	2.95e-05	2.95e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PIK3CA—liver cancer	2.71e-05	2.71e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—AKT1—liver cancer	2.64e-05	2.64e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—TP53—liver cancer	2.62e-05	2.62e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—HRAS—liver cancer	2.5e-05	2.5e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—IL6—liver cancer	2.4e-05	2.4e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—AKT1—liver cancer	2.21e-05	2.21e-05	CbGpPWpGaD
